Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
Vansteenkiste, Johan F, Cho, Byoung Chul, Vanakesa, Tonu, De Pas, Tommaso, Zielinski, Marcin, Kim, Moon Soo, Jassem, Jacek, Yoshimura, Masahiro, Dahabreh, Jubrail, Nakayama, Haruhiku, Havel, Libor, KoМова:
english
Журнал:
The Lancet Oncology
DOI:
10.1016/s1470-2045(16)00099-1
Date:
April, 2016
Файл:
PDF, 520 KB
english, 2016
File converter
Більше результатів пошуку
More benefits 
